{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":1,"sponsored":0,"items":[{"id":"n_7et3yemvpid2i2u3lh6a","seq":1635499,"kind":"article","title":"Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals","url":"https://www.fool.com/coverage/etfs/2026/10/04/better-state-street-healthcare-etf-xbi-s-biotech-focus-vs-xph-targeting-pharmaceuticals","published":"2026-10-04T04:50:00Z","seen":"2026-10-04T07:50:42Z","lang":"en","source":{"id":"fool.com","name":"fool.com","domain":"fool.com","outlet":{"wikidata":"Q7752442","name":"The Motley Fool","type":"other","country":"US","designations":["dot-com company"]}},"via":"gdelt-gkg-english","topics":["economy"],"authors":["Robert Izquierdo"],"entities":[{"id":"Q32143733","name":"xeroderma pigmentosum group D","type":"other"}],"story":"st_4bdsi6z3o3fpxea4hdoq","category":"economy-business","category_p":0.48,"category2":"health","sentiment":"neutral","tone":-0.26,"political":0.27}]}